TIFFANY PENHALLURICK: Open Payments
NPI 1083952147 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $217 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $55 |
| UCB, Inc. | 2 | $52 |
| Amgen Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $15 |
Products named: TREMFYA, Bimzelx, TEPEZZA, PREVNAR 20, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
